Psychologists in Centereach, NY Accepting Medicare
5 Psychologists found. Showing 1 - 5
 Dr. Anthony J Anzalone, PSY.D. Psychologist - Cognitive & Behavioral Medicare: Accepting Medicare Assignments Practice Location: 1919 Middle Country Rd, Centereach, NY 11720 Phone: 631-209-5343 Fax: 631-648-7655 |
 Dr. Amanda Lea Grodewald-adler, PSY.D. Psychologist - Cognitive & Behavioral Medicare: Medicare Enrolled Practice Location: 1919 Middle Country Rd, Suite 308, Centereach, NY 11720 Phone: 631-209-5343 Fax: 631-648-7655 |
Dr. Michael Leonard Nissenbaum, PH.D. Psychologist - Cognitive & Behavioral Medicare: Accepting Medicare Assignments Practice Location: 2100 Middle Country Rd, Suite 28w, Centereach, NY 11720 Phone: 631-737-9500 Fax: 631-737-9512 |
Dr. Sean Barry Haggerty, PH.D. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 1919 Middle Country Rd, Suite 201, Centereach, NY 11720 Phone: 631-689-6560 Fax: 631-689-6560 |
Les Weinberg, PH.D. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 2535 Middle Country Rd, Centereach, NY 11720 Phone: 631-737-1782 Fax: 631-737-1782 |
News Archive
Medicare prescription drug plan premiums to average 11 percent rise in 2010
Premiums for Medicare Part D plans will rise an average of 11 percent next year, the Milwaukee Journal Sentinel reports. The cost for all Medicare prescription plans has increased 50 percent nationally since 2006.
Monitoring individuals with chronic HBV is cost-effective strategy for China
A novel study determined that monitoring inactive chronic hepatitis B (HBV) carriers is a cost-effective strategy for China. However, results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that increasing treatment, monitoring and adherence to therapy are necessary to achieve significant health benefits at the population level.
Political cartoon: 'Don't Go Breakin' My Heart?'
Kaiser Health News provides a fresh take on health policy developments with "Don't Go Breakin' My Heart?" by Gary Markstein.
Cubist submits ceftolozane/tazobactam NDA for treatment of cUTI and cIAI
Cubist Pharmaceuticals, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for approval of its investigational antibiotic ceftolozane/tazobactam for the treatment of Complicated Urinary Tract Infections (cUTI) and Complicated Intra-Abdominal Infections (cIAI).
Study shows how specific nutritional combination may help maintain healthy breast tissue
Researchers from Canada and the United States today told attendees of the Experimental Biology 2011 Scientific Meeting that they have uncovered a possible means of enabling women to favorably influence whether the estrogens in their bodies take a "beneficial path" or a "disease-potential" path.
› Verified 3 days ago
Pharmacists
Clinical Social Workers
Dentists
Occupational Therapists
Counselors
Psychologists